Results 121 to 130 of about 30,645 (194)

HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection. [PDF]

open access: yesJHEP Rep, 2019
Ferrando-Martinez S   +7 more
europepmc   +1 more source

The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment. [PDF]

open access: yesFront Cell Infect Microbiol
Zhang Y   +7 more
europepmc   +1 more source

Erratum to 'KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA)' [Clin Mol Hepatol 2026;32:1029-1116]. [PDF]

open access: yesClin Mol Hepatol
Choi WM   +18 more
europepmc   +1 more source

CS1-02 The Roleof HBV Viral Quasispeciesin HBeAg Seroconversion

open access: yesInternational Journal of Infectious Diseases, 2009
openaire   +1 more source

Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver

open access: yesPrediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver
長崎大学学位論文 [学位記番号]博(医歯薬)甲第554号 [学位授与年月日]平成24年12月5日 (2012-12-05)
openaire   +1 more source

Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study. [PDF]

open access: yesJ Viral Hepat
Zheng S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy